SEMA4A and metabolic dysfunction-associated steatotic liver disease: While SEMA4A was not significantly altered (and this was not associated with rs536857 SNP), SEMA4D expression was significantly higher in both serum and NAFLD livers, and its expression correlated with the fibrosis stage.